AVDL
Avadel Pharmaceuticals
AVDL
AVDL
82 hedge funds and large institutions have $284M invested in Avadel Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 24 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 24
7% less capital invested
Capital invested by funds: $306M → $284M (-$21.3M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $284K
Holders
82
Holding in Top 10
4
Calls
–
Puts
$284K
Top Buyers
| 1 | +$5.65M | |
| 2 | +$2.49M | |
| 3 | +$2.1M | |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$1.87M |
| 5 |
Renaissance Technologies
New York
|
+$1.32M |
Top Sellers
| 1 | -$5.94M | |
| 2 | -$4.5M | |
| 3 | -$2.88M | |
| 4 |
William Blair & Company
Chicago,
Illinois
|
-$1.99M |
| 5 |
FPC
Falcon Point Capital
San Francisco,
California
|
-$1.84M |